oxybutynin has been researched along with Carcinoma, Basal Cell in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spyropoulou, GA | 1 |
| Pavlidis, L | 1 |
| Lampros, E | 1 |
| Demiri, E | 1 |
1 other study available for oxybutynin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Transdermal Patch of Glyceryl Trinitrate to Enhance Survival of Random Pattern Skin Flaps.
Topics: Carcinoma, Basal Cell; Female; Graft Rejection; Graft Survival; Humans; Male; Nitroglycerin; Prognos | 2018 |